Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Sees Large Increase in Short Interest

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 18,020,000 shares, an increase of 12.8% from the October 15th total of 15,980,000 shares. Approximately 26.4% of the company’s shares are sold […]

Leave a Reply

Your email address will not be published.

Previous post Gillette Children’s Hospital in St. Paul adds specialty center for clinical care, therapy
Next post Calamos Convertible Opportunities and Income Fund (NASDAQ:CHI) Short Interest Update